Membership
Our Members
EMIG has over 250 member companies and organisations - including Associate Members e.g., companies providing essential support services to the life sciences ecosystem. Patient Charities, research policy organisations and universities enjoy free membership.
Collectively, we represent the breadth of the health and medicines ecosystem, which means EMIG has become a platform for greater knowledge and ideas exchange.
The extensive knowledge and experience of the people in our Membership constitutes our Network and we use the Network to help our Members as they need it.
For Members
Each EMIG Member has an equal voice in representation and determining policy. No problem is too big or too small because we are not just an association, we are a network.
Our 13 special interest groups reflect EMIG's primary areas of focus, determined by our members. These are the vehicles for networking, information exchange, and policy development.
They complement our Quarterly Meetings where c. 140 members meet to hear prominent speakers address the issues of the day.
What is the EMIG platform?
Our exclusive platform enhances your membership with a personalised dashboard that provides easy access to:
Network
Submit questions or requests anonymously to the Network and receive curated responses, or search the directory for previously asked questions
Events
View and register for upcoming events by interest group, track your personal event schedule, and join live sessions directly through the platform
Resources
Quick access to documents, videos, and podcasts
Maximise your membership benefits with EMIG Online
Featured Events
Below are upcoming events that may be relevant to EMIG members, register your attendance now.
The EU Pharma Package
Zoom WebinarHosted by: ExternalAgenda: The EU Pharma Package - Paul Ranson, EMIG Legal Advisor A registration link will be posted on here when we are closer to the webinar date.
EMIG Quarterly Meeting
London
Hosted by: EMIGAgenda: Application of AI and Pharma; James Pound, Interim Executive Director of Innovation and Compliance, MHRA speaking about the MHRA and Future Innovation; Panel to discuss and answer questions on what we should expect from the new PM and Government:
EMIG Wales Special Interest Group
Zoom WebinarHosted by: EMIGAgenda: David Hutchings will give an overview of what work the Value Based Medicines Group do and cover what industry should know about how they work.
EMIG Patient Organisation Webinar #2
Zoom WebinarHosted by: EMIGAgenda: About the series The need for a multi-stakeholder, whole-system discussion on how the UK can deliver better, less fragmented, and more balanced policies has never been greater. This discussion will be the focus of the webinar series and face-to-face meeting, as part of the relaunched EMIG PO SIG.
Featured Network Questions
Tap into the collective expertise of the EMIG network. Browse recent questions and curated responses, or submit your own inquiries to connect with industry peers.
We are seeking a consultant with expertise in preparing nitrosamine risk assessments.
According to the new PMCPA package deal guidance the company should ensure service providers are adequately trained in relevant requirements of the ABPI Code, including transparency.
Can anyone recommemd a regulatory consultant experienced in pre-vetting with the MHRA?
We are looking for an AI Consultancy who can train us
Featured Resources
Our resources library offers easy access to useful materials including presentations, documents, videos and podcasts. The resources are organised by most recent date upload but you can sort, filter and search by the name of the event, category or file type.
Commercial
UK FRN Single National Pharmacy Report
Commercial
UKFRN Future Pharmacy Report
Commercial
UKFRN 10 Year Plan report
Market Access
Richard Williams Spring Newsletter